Corinne Lacombe

1.3k total citations
21 papers, 810 citations indexed

About

Corinne Lacombe is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Corinne Lacombe has authored 21 papers receiving a total of 810 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 9 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in Corinne Lacombe's work include Immunodeficiency and Autoimmune Disorders (6 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers) and Blood disorders and treatments (3 papers). Corinne Lacombe is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (6 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers) and Blood disorders and treatments (3 papers). Corinne Lacombe collaborates with scholars based in France, Vietnam and Switzerland. Corinne Lacombe's co-authors include Gregory P. Martin, Pierre Grève, Frank Bridoux, Guy Touchard, Pièrre Aucouturier, Nathalie Quellard, Éstelle Desport, Jean‐Michel Goujon, Jean‐Louis Preud'homme and Sébastien Bender and has published in prestigious journals such as Blood, PLoS ONE and American Journal of Kidney Diseases.

In The Last Decade

Corinne Lacombe

21 papers receiving 785 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Corinne Lacombe France 14 390 244 208 149 117 21 810
Michael G. Strainic United States 16 263 0.7× 1.1k 4.7× 136 0.7× 19 0.1× 128 1.1× 23 1.5k
Linda Beischel United States 18 217 0.6× 381 1.6× 249 1.2× 16 0.1× 123 1.1× 34 865
Whitney Rabacal United States 15 163 0.4× 607 2.5× 97 0.5× 42 0.3× 41 0.4× 23 970
Hideharu Sekine Japan 17 146 0.4× 796 3.3× 172 0.8× 17 0.1× 133 1.1× 49 1.1k
Yasuhiko Munakata Japan 19 238 0.6× 201 0.8× 17 0.1× 205 1.4× 118 1.0× 36 1.3k
Donald J. McCrann United States 14 216 0.6× 110 0.5× 72 0.3× 22 0.1× 69 0.6× 31 728
Rachel J. Thomas Australia 11 826 2.1× 94 0.4× 66 0.3× 34 0.2× 16 0.1× 14 1.3k
Anna Rocca France 15 491 1.3× 123 0.5× 135 0.6× 6 0.0× 116 1.0× 29 709
Pamela J. Daffern United States 12 128 0.3× 512 2.1× 31 0.1× 43 0.3× 134 1.1× 13 953
Nitza G. Shoham Israel 10 959 2.5× 621 2.5× 135 0.6× 22 0.1× 168 1.4× 10 1.3k

Countries citing papers authored by Corinne Lacombe

Since Specialization
Citations

This map shows the geographic impact of Corinne Lacombe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Corinne Lacombe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Corinne Lacombe more than expected).

Fields of papers citing papers by Corinne Lacombe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Corinne Lacombe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Corinne Lacombe. The network helps show where Corinne Lacombe may publish in the future.

Co-authorship network of co-authors of Corinne Lacombe

This figure shows the co-authorship network connecting the top 25 collaborators of Corinne Lacombe. A scholar is included among the top collaborators of Corinne Lacombe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Corinne Lacombe. Corinne Lacombe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morel, Franck, P. Levillain, Charles Bodet, et al.. (2017). Interleukin-17A-induced production of acute serum amyloid A by keratinocytes contributes to psoriasis pathogenesis. PLoS ONE. 12(7). e0181486–e0181486. 24 indexed citations
2.
Abraham, Julie, Éstelle Desport, Benôıt Marin, et al.. (2015). Hepatocyte growth factor measurement in AL amyloidosis. Amyloid. 22(2). 112–116. 8 indexed citations
3.
Bonaud, Amélie, Sébastien Bender, Guy Touchard, et al.. (2015). A mouse model recapitulating human monoclonal heavy chain deposition disease evidences the relevance of proteasome inhibitor therapy. Blood. 126(6). 757–765. 21 indexed citations
4.
Javaugue, Vincent, Alexandre Karras, François Glowacki, et al.. (2013). Long-term Kidney Disease Outcomes in Fibrillary Glomerulonephritis: A Case Series of 27 Patients. American Journal of Kidney Diseases. 62(4). 679–690. 62 indexed citations
5.
Desport, Éstelle, Frank Bridoux, Christophe Sirac, et al.. (2012). AL Amyloidosis. Orphanet Journal of Rare Diseases. 7(1). 54–54. 166 indexed citations
6.
Verdon, Julien, et al.. (2011). Anti-Legionella activity of staphylococcal hemolytic peptides. Peptides. 32(5). 845–851. 28 indexed citations
7.
Bridoux, Frank, Éstelle Desport, Véronique Frémeaux‐Bacchi, et al.. (2011). Glomerulonephritis With Isolated C3 Deposits and Monoclonal Gammopathy. Clinical Journal of the American Society of Nephrology. 6(9). 2165–2174. 84 indexed citations
8.
Sirac, Christophe, Sébastien Bender, Arnaud Jaccard, et al.. (2011). Strategies to model AL amyloidosis in mice. Amyloid. 18(sup1). 45–47. 5 indexed citations
9.
Lacombe, Corinne, Mark Lewin, Laurence Monnier‐Cholley, et al.. (2007). Imagerie des pathologies thoraciques chez le patient VIH au stade sida. Journal de Radiologie. 88(9). 1145–1154. 12 indexed citations
10.
Tchernitchko, Dimitri, Stéphane Moutereau, Marie Legendre, et al.. (2005). MEFV analysis is of particularly weak diagnostic value for recurrent fevers in Western European Caucasian patients. Arthritis & Rheumatism. 52(11). 3603–3605. 44 indexed citations
11.
Yi, Fan, Marie‐Odile Jauberteau, Corinne Lacombe, et al.. (2000). Prevalence and Clinical Significance of Anti-phospholipid Antibodies in Multiple Sclerosis: a Study of 89 Patients. Journal of Autoimmunity. 14(3). 259–265. 53 indexed citations
12.
Lacombe, Corinne, et al.. (1999). Heterogeneity of Serum IgG Subclass Deficiencies in B Chronic Lymphocytic Leukemia. Clinical Immunology. 90(1). 128–132. 22 indexed citations
13.
Lacombe, Corinne, Pierre Grève, & Gregory P. Martin. (1999). Overview on the sub-grouping of the crustacean hyperglycemic hormone family. Neuropeptides. 33(1). 71–80. 159 indexed citations
14.
Lacombe, Corinne, et al.. (1997). Selective IgG1 Deficiency. Clinical Immunology and Immunopathology. 84(2). 194–201. 25 indexed citations
15.
Aucouturier, Pièrre, Corinne Lacombe, & Jean‐Louis Preud'homme. (1994). Serum IgG subclass level determination: methodological difficulties and practical aspects.. PubMed. 52(1). 53–6. 13 indexed citations
16.
Aucouturier, Pièrre, Corinne Lacombe, & Jean‐Louis Preud'homme. (1992). Methodological pitfalls in serum IgG2 level measurements by immunoenzymatic assays with monoclonal antibodies. Journal of Clinical Laboratory Analysis. 6(1). 12–16. 6 indexed citations
17.
Aucouturier, Pièrre, et al.. (1992). Frequency of selective IgG subclass deficiency: A reappraisal. Clinical Immunology and Immunopathology. 63(3). 289–291. 8 indexed citations
18.
Aucouturier, Pièrre, Corinne Lacombe, Yvon Lebranchu, et al.. (1989). Serum IgG subclass levels in patients with primary immunodeficiency syndromes or abnormal susceptibility to infections. Clinical Immunology and Immunopathology. 51(1). 22–37. 31 indexed citations
19.
Preud'homme, J L, Corinne Lacombe, Charlotte Cordonnier, et al.. (1989). IgG subclass deficiency in acute myeloid leukemia.. PubMed. 31(5). 349–51. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026